DIPHENHYDRAMINE, METHYLPREDNISOLONE, PARACETAMOL, ublituximab, Ublituximab, ublituximab, CETIRIZINE, DEXAMETHASONE
TG1101-RMS-SC101
Phase 1 small_molecule active
Quick answer
DIPHENHYDRAMINE, METHYLPREDNISOLONE, PARACETAMOL, ublituximab, Ublituximab, ublituximab, CETIRIZINE, DEXAMETHASONE for Relapsing multiple sclerosis, Myasthenia Gravis is a Phase 1 program (small_molecule) at TG THERAPEUTICS, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- TG THERAPEUTICS, INC.
- Indication
- Relapsing multiple sclerosis, Myasthenia Gravis
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active